Teladoc Health (NYSE:TDOC - Get Free Report) had its price target lowered by stock analysts at Truist Financial from $10.00 to $9.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has a "hold" rating on the health services provider's stock. Truist Financial's price target would indicate a potential upside of 28.85% from the company's current price.
A number of other equities research analysts have also recently issued reports on the company. Evercore ISI cut their target price on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating on the stock in a research note on Thursday, May 1st. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research note on Thursday, May 1st. Jefferies Financial Group dropped their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. The Goldman Sachs Group decreased their target price on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Finally, Canaccord Genuity Group lowered their price objective on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Twelve investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Teladoc Health currently has a consensus rating of "Hold" and an average price target of $9.60.
View Our Latest Research Report on Teladoc Health
Teladoc Health Stock Performance
Shares of TDOC stock traded up $0.02 on Tuesday, hitting $6.99. 6,440,588 shares of the stock traded hands, compared to its average volume of 6,247,254. The company's fifty day moving average is $7.30 and its 200 day moving average is $9.22. Teladoc Health has a 1-year low of $6.35 and a 1-year high of $15.21. The company has a market capitalization of $1.23 billion, a PE ratio of -1.21 and a beta of 1.82. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.
Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. On average, equities research analysts predict that Teladoc Health will post -1.16 earnings per share for the current fiscal year.
Insider Activity at Teladoc Health
In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the transaction, the insider now directly owns 64,308 shares of the company's stock, valued at approximately $541,473.36. The trade was a 14.62% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.58% of the company's stock.
Institutional Investors Weigh In On Teladoc Health
A number of institutional investors and hedge funds have recently made changes to their positions in the company. KBC Group NV grew its position in shares of Teladoc Health by 72.3% during the 4th quarter. KBC Group NV now owns 8,849 shares of the health services provider's stock worth $80,000 after buying an additional 3,714 shares during the period. Robeco Institutional Asset Management B.V. boosted its stake in Teladoc Health by 21.8% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider's stock valued at $6,365,000 after acquiring an additional 125,111 shares during the last quarter. Murphy Pohlad Asset Management LLC acquired a new stake in Teladoc Health during the 4th quarter worth $458,000. Summit Trail Advisors LLC bought a new stake in shares of Teladoc Health during the 4th quarter valued at $92,000. Finally, Allspring Global Investments Holdings LLC bought a new stake in shares of Teladoc Health during the 4th quarter valued at $2,859,000. Institutional investors own 76.82% of the company's stock.
Teladoc Health Company Profile
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
